Active ingredientSultiameCat. No. P-S130-001CAS 61-56-3Family · Pharmaceutical analytical standards
Sultiame
An anticonvulsant of the sulfonamide family that inhibits carbonic anhydrase, synthesised in the mid-1950s and introduced in Europe in the early 1960s: it is used for benign focal epilepsies of childhood, such as rolandic epilepsy. This family brings together the active ingredient and labelled standards.
Did you know?Although it is a sulfonamide it has no antibacterial activity at all; in 1988 the German child neurologist Hermann Doose discovered its efficacy in benign childhood epilepsies, reviving its use.
Go to the active ingredient →Active ingredientSultiameCat. No. P-S130-001CAS 61-56-3
Isotopically labelledSultiame-d4Cat. No. P-S130-002CAS 1795021-05-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.